Metronidazole During Pregnancy: Safety, Evidence and Use

Why metronidazole may be prescribed during pregnancy

Metronidazole is an antimicrobial used for certain anaerobic and protozoal infections. It is commonly prescribed orally or as a vaginal gel for bacterial vaginosis and trichomoniasis.

Treating an infection during pregnancy can be important. The appropriate choice depends on what infection is present and the person's clinical circumstances; vaginal symptoms alone do not establish which infection needs treatment. A healthcare professional can assess the cause and whether metronidazole is suitable.

The decision is therefore a balance: the possible risks of medicine exposure must be considered alongside the benefits of treating the infection and the risks of leaving it untreated. Do not use leftover metronidazole or select a formulation based on symptoms without clinical advice.

What the evidence shows about pregnancy outcomes

Available human pregnancy data, based almost entirely on oral exposure, do not overall indicate an increased risk of congenital malformations after metronidazole exposure. This is reassuring at a population level, but it cannot guarantee an individual pregnancy outcome.

The available evidence also shows no indication of increased risks of preterm delivery, low infant birth weight, intrauterine death or neonatal complications following exposure. These findings do not establish that risk is zero.

Some studies have found an association between metronidazole exposure early in pregnancy and miscarriage. It is uncertain whether the medicine causes this association: the infection being treated, along with other possible factors, may also affect miscarriage risk. The evidence does not establish that metronidazole causes or prevents miscarriage.

Studies have not established whether exposure before birth affects a child's later behavior or learning. That is an evidence gap, not evidence that such effects have been identified.

Metronidazole during the first trimester

Metronidazole is not categorically prohibited during the first trimester. Early pregnancy is a key period of development, which is one reason medicine exposures can raise concern. Available human data do not overall indicate an increased risk of congenital malformations, and early-pregnancy miscarriage findings are difficult to separate from the effects of the infection being treated and other factors.

If you took metronidazole before realizing you were pregnant, contact your maternity clinician and share the product, route, regimen and timing. Exposure alone would not usually be considered a reason for pregnancy termination or additional fetal monitoring, though other individual risk factors may affect assessment.

A UK pregnancy-information source reports a manufacturer caution against a single high-dose oral regimen during pregnancy when oral treatment is appropriate. This is a regimen-specific caution, not a ban on all oral metronidazole or a blanket first-trimester restriction. Ask your clinician about your particular prescription rather than changing it yourself.

Tablets versus vaginal gel in pregnancy

Metronidazole is available in oral and vaginal forms. The appropriate route and regimen depend on the infection and clinical judgment; one form should not be substituted for another without advice from a healthcare professional.

Pregnancy-outcome evidence is based predominantly on oral exposure. That means the evidence is not equally extensive for every route, but it does not show that vaginal gel is automatically safer than tablets.

UK pregnancy guidance reports a manufacturer-related caution about a single high-dose oral regimen when oral treatment is appropriate. This does not apply as a blanket prohibition to all oral regimens. If you are unsure why a particular form was prescribed, ask your doctor, midwife or pharmacist to explain the plan.

What to do before, during or after treatment

Make sure the prescriber knows you are pregnant, or might be pregnant. Follow the prescribed product and regimen, and speak with your doctor, midwife or pharmacist before changing the dose, route or duration or stopping treatment.

If you have already used metronidazole, exposure alone would not usually mean that extra fetal monitoring is needed. Other health or pregnancy factors may affect what advice is appropriate, so share the details of the exposure with your maternity clinician.

Ask a healthcare professional if you have questions about the diagnosis or regimen, experience concerning effects, or have symptoms that are worsening. Population evidence can be reassuring, but the right treatment decision still depends on the infection and individual clinical circumstances.